ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 64 filers reported holding ARCUS BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $962,802 | -15.5% | 53,638 | -4.4% | 0.00% | -50.0% |
Q2 2023 | $1,139,147 | +9.1% | 56,088 | -2.0% | 0.00% | 0.0% |
Q1 2023 | $1,044,422 | -13.1% | 57,260 | -1.5% | 0.00% | 0.0% |
Q4 2022 | $1,201,901 | -19.8% | 58,119 | +1.4% | 0.00% | -33.3% |
Q3 2022 | $1,499,000 | +1.3% | 57,310 | -1.9% | 0.00% | +50.0% |
Q2 2022 | $1,480,000 | -11.1% | 58,422 | +10.8% | 0.00% | 0.0% |
Q1 2022 | $1,664,000 | -28.6% | 52,736 | -8.5% | 0.00% | -33.3% |
Q4 2021 | $2,332,000 | +18.4% | 57,618 | +2.0% | 0.00% | 0.0% |
Q3 2021 | $1,970,000 | +14.9% | 56,490 | -9.5% | 0.00% | +50.0% |
Q2 2021 | $1,714,000 | -4.0% | 62,411 | -1.8% | 0.00% | 0.0% |
Q1 2021 | $1,785,000 | +7.8% | 63,560 | -0.4% | 0.00% | 0.0% |
Q4 2020 | $1,656,000 | +51.5% | 63,790 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,093,000 | -10.4% | 63,790 | +29.3% | 0.00% | 0.0% |
Q2 2020 | $1,220,000 | +78.1% | 49,316 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $685,000 | +34.1% | 49,316 | -2.5% | 0.00% | 0.0% |
Q4 2019 | $511,000 | +11.1% | 50,587 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $460,000 | +17.6% | 50,587 | +3.0% | 0.00% | 0.0% |
Q2 2019 | $391,000 | -36.3% | 49,123 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $614,000 | +16.1% | 49,123 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $529,000 | +169.9% | 49,123 | +250.1% | 0.00% | – |
Q3 2018 | $196,000 | +102.1% | 14,033 | +77.5% | 0.00% | – |
Q2 2018 | $97,000 | – | 7,908 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |